Preventing dementia for those with a family history requires a combination of cardiovascular health management, cognitive engagement, and lifestyle modifications. According to medical research, individuals can lower their risk by controlling blood pressure, maintaining a healthy weight, and staying socially active, even when genetic predispositions are present. How can you reduce dementia risk if it … Read more
Chronic stress and a dysregulated nervous system are identified as drivers of poor gut health. According to nutritionist Deepsikha Jain, a regulated nervous system is essential for proper digestion, as it enables the body to activate the parasympathetic “rest and digest” state necessary for optimal enzyme production and bowel coordination. Why Does Your Nervous System … Read more
_6e98296023b34dfabc133638c1ef5d32-620x480.jpg)
University of Arizona researchers have developed an experimental drug, XL20, that shows potential to protect nerve cells from damage associated with amyotrophic lateral sclerosis (ALS). According to a study published in Nature Aging, the drug targets a specific region of the TDP-43 protein to prevent toxic clumping, a process that contributes to neurodegeneration in ALS … Read more
A ten-week cognitive rehabilitation program significantly improves executive function and goal attainment for patients suffering from long Covid, according to a clinical trial led by University College London (UCL) researchers. Published in JAMA Network Open, the study found that 53% of participants receiving the therapy maintained substantial improvements six months later, compared to just 15% … Read more
Brain-computer interface (BCI) technology, long developed in isolated silos for vision and touch, relies on nearly identical neural and computational principles. According to a review published in Nature Reviews Bioengineering led by Giacomo Valle of Sweden’s Chalmers University of Technology, merging these fields could accelerate the development of prostheses for patients with sight loss or … Read more
Researchers at McMaster University have developed a new immunotherapy strategy that simultaneously attacks glioblastoma tumors and the immune cells that help them grow. By using Chimeric Antigen Receptor T-cell (CAR-T) therapy to target the GPNMB protein, the study—published July 1 in Nature—demonstrated the ability to eliminate detectable tumors and achieve long-term disease-free survival in pre-clinical … Read more
Lecanemab is now approved in Canada for treating early-stage Alzheimer’s disease, though clinical experts warn the benefits remain modest and the treatment process is resource-intensive. According to the Canadian Medical Association Journal (CMAJ), the medication requires specialized diagnostics and carries risks of serious adverse effects, necessitating careful shared decision-making between physicians, patients, and caregivers. Why … Read more
Exclusive breastfeeding for up to six months is associated with a lower risk of ADHD symptoms in children between the ages of three and eight, according to a study published in Biological Psychiatry. Researchers from the University of Bergen analyzed data from 37,600 families in the Norwegian Mother, Father and Child Cohort Study (MoBa) to … Read more
Women who have used hormonal birth control or menopausal hormone therapy (MHT) show structural brain differences associated with healthier aging, according to research published in the journal NeuroImage. A study of 459 women aged 65 to 80 found that lifetime exposure to these hormones correlates with greater gray matter volume and cortical thickness in brain … Read more
High-dose docosahexaenoic acid (DHA) supplementation successfully increases omega-3 levels in the human brain but fails to halt cognitive decline or structural brain changes, according to a randomized clinical trial published in eBioMedicine. Researchers monitored 365 older adults over two years, finding that while the supplement reached the central nervous system, it provided no measurable benefit … Read more